Hematopathology Fellowship Program

Hematopathology Fellowship Program
The Hematopathology Fellowship Program at City of Hope is a two-year program primarily designed for fellows interested in academic hematopathology.  Supporting one of the largest bone marrow transplantation programs in the United States, and enjoying an active consultation service, the division evaluates more than 3,000 diagnostic specimens involving peripheral blood, bone marrow, lymph nodes and extranodal biopsies each year.  The program has a rich history, which includes notable past faculty such as Drs. Henry Rappaport, Daniel Arber, and Lawrence Weiss.  Multiparameter studies are emphasized, including analyses by morphology, immunohistochemistry, flow cytometry, and cytogenetic and molecular techniques, all supported by active in-house laboratories.  The first fellowship year is ACGME-accredited and focuses on diagnostic hematopathology.  Didactic lectures, Pathology Grand Rounds , slide seminars, patient care conferences, bimonthly research meetings, and journal club are part of the educational experience.  During the second year, fellows continue their research projects and participate as instructors in independent hematopathology case signout within the division, preparing them for academic careers.

________________________________________

Contact Information
City of Hope
Hematopathology Coordinator- Department of Pathology
1500 E. Duarte Road
Duarte, CA 91010
Phone (626) 256-4673  ext. 62456
____________________________________________________________________________________________________________________________________________

Program Faculty
Michelle Afkhami, M.D., Associate Medical Director, Clinical Molecular Diagnostic Laboratory; Assistant Clinical Professor, Department of Pathology ,
Bharat Nathwani, M.D., Consultation Practice Director, Clinical Professor, Department of Pathology
________________________________________

Requirements
Candidates must be in good standing in an ACGME accredited program in Anatomic and Clinical Pathology, (or equivalent program in Canada recognized by American Board of Pathology), and be eligible for Pathology Boards and a California medical license upon completion of residency training.

________________________________________

Positions and Application Process
Up to 3 ACGME accredited positions are available each year.  For positions beginning in July, please send a brief cover letter, three (3) reference letters, and C.V. (or standardized fellowship application) at least a year and a half in advance (e.g. September 2015 for a July 2017 start date) to:

City of Hope National Medical Center
Attn: Alejandra Baldrias
Hematopathology Coordinator - Department of Pathology
1500 E. Duarte Road
Duarte, CA  91010
Phone (626) 256-4673 ext. 62456
Email: abaldrias@coh.org
________________________________________

Select Presentations and Publications Written by Faculty and Fellows
 
Song L, Feldman AL, Murata-Collins J, Bedell V, Nathwani BN, Weisenburger DD, Song JY.  Cyclin D1 expression in T cell lymphomas (USCAP 2015 platform presentation).
 
Low L, Song JY, Mei M, Krishnan A, Nademanee A, Popplewell L, Chen R, Spielberger R, Cai J, Chen YY, Zumel S, Gaal K, Aoun P, Weisenburger DD, Kim YS.  Coexpression of MYC and BCL2 protein in diffuse large B cell lymphoma predicts a poor outcome in patients treated with autologous hematopoietic stem cell transplantation (USCAP 2015).
 
Batra R, Weisenburger D, Snyder D, Bedell V, Murata-Collins J, Gaal K. Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia (USCAP 2014).
 
Zhang N, Reddi DM, Weisenburger DD, Kim Y.  Follicular Lymphoma with Marginal Zone Differentiation, an Institutional Experience (USCAP 2014).
 
Bautista-Quach MA, Nademanee A, Weisenburger DD, Chen W, Kim YS. Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules. Clin Breast Cancer. 2013;13(6):492-495.  PMID: 24267734
 
Kim YS, Wu H, Pawlowska AB, Bautista-Quach MA, Huang Q, Gaal K, Chang KL. Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm. Am J Surg Pathol. 2013;37(3):453-458. PMID: 23388130
 
Pan ZG, Zhang QY, Lu ZB, Quinto T, Rozenvald IB, Liu LT, Wilson D, Reddy V, Huang Q, Wang HY, Ren YS. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Am J Surg Pathol. 2012;36(8):1129-1140.  PMID: 22790853
 
Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q.  Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Am J Clin Pathol 2008; 129(4):624-9.  PMID: 18343790
________________________________________
 
Program Graduates

Rashmi Batra, Santa Clara Valley Medical Center, Graduated 2014
Nan Zhang, University of Buffalo, Graduated 2014
Kali Freeman, Yosemite Pathology Group, Graduated 2014
Tobi Quinto, UCLA Surgical Pathology Fellowship, Graduated 2014
Marnelli Aguilar Bautista-Quach, Yosemite Pathology Group, Graduated 2013
Hannah Wong, Diagnostic Pathology Medical Group, Graduated 2012
Zenggang Pan, University of Colorado, Denver, Graduated 2012
Aihong Liu, University of San Francisco, Graduated 2012
Ji Lu, Kaiser Permanente, Northern California, Graduated 2011
Jyotsna Reddy, Kaiser Permanente, Sacramento, Graduated 2011
Hung Luu, University of Texas, Southwestern, Graduated 2010
Mingyi Chen, University of California, Davis, Graduated 2010
Renuka Agrawal, Clarient, Graduated 2010
Youn Kim, Kaiser Permanente, Bellflower, Graduated 2009
Monica Caro-Mosquera, Hoag Memorial Hospital, Graduated 2009
Angie Pham, Seattle, WA, Graduated 2009
Steve Lum, The Queen's Medical Center, Graduated 2008
Kate Grimm, Clarient, Graduated 2008
Veronica Rausei-Mills, Hoag Memorial Hospital, Graduated 2007
Sherif Rezk, University of California, Irvine, Graduated 2007